Given that the role of LRP5, PLS3, and WNT1 in the development of osteoporosis was only discovered 10–15 years ago, and the rarity of these pathogenic variants, their associated morbidity and prognosis are still largely undetermined. This evidence concerns the gene LRP5 and osteoporosis.